Skip to main content Accessibility help
×
Home

Randomised, double-blinded, placebo-controlled, clinical trial of ozone therapy as treatment of sudden sensorineural hearing loss

  • A Ragab (a1), E Shreef (a1), E Behiry (a1), S Zalat (a2) and M Noaman (a1)...

Abstract

Objective:

To investigate the safety and efficacy of ozone therapy in adult patients with sudden sensorineural hearing loss.

Design:

Prospective, randomised, double-blinded, placebo-controlled, parallel group, clinical trial.

Subjects:

Forty-five adult patients presented with sudden sensorineural hearing loss, and were randomly allocated to receive either placebo (15 patients) or ozone therapy (auto-haemotherapy; 30 patients). For the latter treatment, 100 ml of the patient's blood was treated immediately with a 1:1 volume, gaseous mixture of oxygen and ozone (from an ozone generator) and re-injected into the patient by intravenous infusion. Treatments were administered twice weekly for 10 sessions. The following data were recorded: pre- and post-treatment mean hearing gains; air and bone pure tone averages; speech reception thresholds; speech discrimination scores; and subjective recovery rates.

Results:

Significant recovery was observed in 23 patients (77 per cent) receiving ozone treatment, compared with six (40 per cent) patients receiving placebo (p < 0.05). Mean hearing gains, pure tone averages, speech reception thresholds and subjective recovery rates were significantly better in ozone-treated patients compared with placebo-treated patients (p < 0.05).

Conclusion:

Ozone therapy is a significant modality for treatment of sudden sensorineural hearing loss; no complications were observed.

Copyright

Corresponding author

Address for correspondence: Professor Ahmed Ragab, Lecturer and Consultant, ORL Head and Neck Surgery Department, Menofia University Hospital, 73 Sayed St, Tanta, Egypt. Fax: 00 20 40 3315000 E-mail: ahmedragab2000@hotmail.com

References

Hide All
1 Byl, FM. Sudden hearing loss: Eight years experience and suggested prognostic table. Laryngoscope 1984;94:647–61
2 Simmons, FB. Sudden idiopathic sensorineural hearing loss: some observations. Laryngoscope 1973;83:1221–7
3 Wilson, WR, Byl, FM, Laird, N. The efficacy of steriods in the treatment of idiopathic sudden hearing loss. Arch Otolaryngol 1980;106:772–6
4 Wilson, WR, Veltri, RW, Laird, N, Sprinkle, PM. Viral and epidemiologic studies of idiopathic sudden hearing loss. Otolaryngol Head Neck Surg 1983;91:653–8
5 Horn, CE, Himel, HN, Selesnick, SH. Hyperbaric oxygen therapy for sudden sensorineural hearing loss: a prospective trial of patients failing steroid and antiviral treatment. Otol Neurotol 2005;26:882–9
6 Simmons, FB. Theory of membrane breaks in sudden hearing loss. Arch Otolaryngol 1968;88:41–8
7 Merchant, SN, Adams, JC, Nadol, JB Jr. Pathology and pathophysiology of idiopathic sudden sensorineural hearing loss. Otol Neurotol 2005;26:151–60
8 Schuknecht, HF. Pathology of the Ear, 2nd edn. Philadelphia: Lea & Febiger, 1993
9 Mattox, DE, Simmons, FB. Natural history of sudden sensorineural hearing loss. Ann Otol Rhinol Laryngol 1977;86:463–80
10 Doyle, KJ, Bauch, C, Battista, R, Beatty, C, Hughes, GB, Mason, J et al. Intratympanic steroid treatment: a review. Otol Neurotol 2004;25:1034–9
11 Travagli, V, Zanardi, I, Bocci, V. A realistic evaluation of the action of ozone on whole human blood. Int J Biol Macromol 2006;39:317–20
12 Halliwell, B, Clement, MV, Long, LH. Hydrogen peroxide in the human body. FEBS Lett 2000;486:1013
13 Bocci, VA. Scientific and medical aspects of ozone therapy. State of the art. Arch Med Res 2006;37:425–35
14 Madej, P, Plewka, A, Madej, JA, Nowak, M, Plewka, D, Franik, G et al. Ozonotherapy in an induced septic shock. I. Effect of ozonotherapy on rat organs in evaluation of free radical reactions and selected enzymatic systems. Inflammation 2007;30:52–8
15 Di Paolo, N, Bocci, V, Salvo, DP, Palasciano, G, Biagioli, M, Meini, S et al. Extracorporeal blood oxygenation and ozonation (EBOO): a controlled trial in patients with peripheral artery disease. Int J Artif Organs 2005;28:1039–50
16 Di Paolo, N, Gaggiotti, E, Galli, F. Extracorporeal blood oxygenation and ozonation: clinical and biological implications of ozone therapy. Redox Rep 2005;10:121–30
17 Weng, SF, Chen, YS, Hsu, CJ, Tseng, FY. Clinical features of sudden sensorineural hearing loss in diabetic patients. Laryngoscope 2005;115:1676–80
18 Eisenman, D, Arts, HA. Effectiveness of treatment for sudden sensorineural hearing loss. Arch Otolaryngol Head Neck Surg 2000;126:1161–4
19 Aoki, D, Takegoshi, H, Kikuchi, S. Evaluation of super-high-dose steroid therapy for sudden sensorineural hearing loss. Otolaryngol Head Neck Surg 2006;134:783–7
20 Choung, YH, Park, K, Shin, YR, Cho, MJ. Intratympanic dexamethasone injection for refractory sudden sensorineural hearing loss. Laryngoscope 2006;116:747–52
21 Xenellis, J, Papadimitriou, N, Nikolopoulos, T, Maragoudakis, P, Segas, J, Tzagaroulakis, A et al. Intratympanic steroid treatment in idiopathic sudden sensorineural hearing loss: a control study. Otolaryngol Head Neck Surg 2006;134:940–5
22 Gianoli, GJ, Li, JC. Transtympanic steroids for treatment of sudden hearing loss. Otolaryngol Head Neck Surg 2001;125:142–6
23 Battista, RA. Intratympanic dexamethasone for profound idiopathic sudden sensorineural hearing loss. Otolaryngol Head Neck Surg 2005;132:902–5
24 Tucci, DL, Farmer, JC Jr, Kitch, RD, Witsell, DL. Treatment of sudden sensorineural hearing loss with systemic steroids and valacyclovir. Otol Neurotol 2002;23:301–8
25 Uri, N, Doweck, I, Cohen-Kerem, R, Greenberg, E. Acyclovir in the treatment of idiopathic sudden sensorineural hearing loss. Otolaryngol Head Neck Surg 2003;128:544–9
26 Gordin, A, Goldenberg, D, Golz, A, Netzer, A, Joachims, HZ. Magnesium: a new therapy for idiopathic sudden sensorineural hearing loss. Otol Neurotol 2002;23:447–51
27 Psifidis, AD, Psillas, GK, Daniilidis, JCh. Sudden sensorineural hearing loss: long-term follow-up results. Otolaryngol Head Neck Surg 2006;134:809–15
28 Suzuki, H, Furukawa, M, Kumagai, M, Takahashi, E, Matsuura, K, Katori, Y et al. Defibrinogenation therapy for idiopathic sudden sensorineural hearing loss in comparison with high-dose steroid therapy. Acta Otolaryngol 2003;123:4650
29 Zadeh, MH, Storper, IS, Spitzer, JB. Diagnosis and treatment of sudden-onset sensorineural hearing loss: a study of 51 patients. Otolaryngol Head Neck Surg 2003;128:92–8
30 Cinamon, U, Bendet, E, Kronenberg, J. Steroids, carbogen or placebo for sudden hearing loss: a prospective double-blind study. Eur Arch Otorhinolaryngol 2001;258:477–80
31 Slattery, WH, Fisher, LM, Iqbal, Z, Friedman, RA, Liu, N. Intratympanic steroid injection for treatment of idiopathic sudden hearing loss. Otolaryngol Head Neck Surg 2005;133:251–9

Keywords

Randomised, double-blinded, placebo-controlled, clinical trial of ozone therapy as treatment of sudden sensorineural hearing loss

  • A Ragab (a1), E Shreef (a1), E Behiry (a1), S Zalat (a2) and M Noaman (a1)...

Metrics

Altmetric attention score

Full text views

Total number of HTML views: 0
Total number of PDF views: 0 *
Loading metrics...

Abstract views

Total abstract views: 0 *
Loading metrics...

* Views captured on Cambridge Core between <date>. This data will be updated every 24 hours.

Usage data cannot currently be displayed